Proteomics Products & Reviews

The ExoBrite™ True EV Membrane Stains are designed to surpass the limitations of traditional membrane dyes and provide near-complete coverage of EVs with unmatched solubility, ensuring accurate and reliable results in your experiments.

High-performance His-tagged protein capture for rapid quantitation, kinetic measurements and epitope binning

The Biotage® Initiator+ Alstra™ simplifies solid phase peptide synthesis with an intuitive interface for easy, customizable workflows. Step-by-step programming, robotic reagent handling, and patented oscillating mixing ensure precise delivery, consistent performance, and uniform resin distribution—delivering accurate, reproducible results for peptides and peptide-like compounds.

Target Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.

Syngeneic urothelial carcinoma model for bladder cancer research and immunotherapy development

Alfa Chemistry provides high-quality oligonucleotide series products including synthesis building blocks and cyclic dinucleotides.

Suitable for plant cell culture, BioReagent, ≥95% (HPLC)

Type VI-S, lyophilized powder, for diagnostic assay manufacturing

Type I-S, 65-85% protein (≥75% of protein is clottable)

Recombinant, expressed in Pichia pastoris, ATPase ≥1000 units/mg protein, lyophilized powder.

Flexible subcellular proteomics for rapid and quantitative spatial phenotyping

Fast track precise spatial multiplexing

Automated Plate Washer

Recombinant or purified CA19-9 antigen, a sialylated Lewis blood group antigen, which is a widely used serum biomarker for pancreatic and gastrointestinal cancers.

High-purity proteins produced through genetic engineering in heterologous expression systems, ensuring consistency, scalability, and reduced lot-to-lot variability for research and development.

Recombinant Human Programmed Death-Ligand 1 (PD-L1/CD274/B7-H1), the primary ligand for PD-1, expressed on tumor and immune cells to suppress anti-tumor immunity.

Recombinant Human Bone Morphogenetic Protein 7 (BMP-7), a TGF-β superfamily member that induces bone and cartilage formation and plays roles in renal development and repair.

An extensive collection of recombinant Cluster of Differentiation (CD) proteins, which are key cell surface markers for immunophenotyping, immune function studies, and therapeutic targeting.

Recombinant Human Bone Morphogenetic Protein 2 (BMP-2), a key regulatory protein that induces bone and cartilage formation, used extensively in orthopedics and stem cell differentiation.

Recombinant Human Apolipoprotein E (ApoE), a key protein in lipid metabolism that plays a central role in cardiovascular health and Alzheimer's disease pathogenesis.

Recombinant Human B-cell lymphoma 2 (BCL-2) protein, a key regulator of apoptosis (programmed cell death) and a well-established oncoprotein in many cancers.

Recombinant Human B-cell Antigen Receptor Complex-associated protein alpha chain (CD79A), a essential component of the B-cell receptor (BCR) and a marker for B-cell lineage.

A focused set of recombinant immune regulatory proteins, such as PD-1, PD-L1, and CTLA-4, essential for research and drug discovery in cancer immunotherapy and autoimmunity.

Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.

A portfolio of recombinant immunoglobulins and cell surface proteins serving as critical targets for the development and functional validation of Chimeric Antigen Receptor T-cell (CAR-T) therapies.